financetom
Business
financetom
/
Business
/
Denmark says its life science firms challenged by Trump order to cut drug prices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Denmark says its life science firms challenged by Trump order to cut drug prices
May 26, 2025 9:34 AM

COPENHAGEN, May 16 (Reuters) - Denmark's business

minister said on Friday Danish life science companies are

challenged by U.S. President Donald Trump's executive order

directing drugmakers to lower drug prices.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Banxa Holdings Up More Than 2% After Reporting
Banxa Holdings Up More Than 2% After Reporting "Positive" Operating Cashflow In February, and Flagging Improvement in March, April
Apr 9, 2024
10:23 AM EDT, 04/09/2024 (MT Newswires) -- Banxa Holdings ( BNXAF ) was up more than 2% at last look on Tuesday after saying that it achieved sustainable positive operating cash flow in February and sees that improving in the coming months. It's encouraging to see that March and April are looking even better, said Banxa ( BNXAF ) Chairman...
Xencor Names Bart Cornelissen as Chief Financial Officer
Xencor Names Bart Cornelissen as Chief Financial Officer
Apr 9, 2024
10:27 AM EDT, 04/09/2024 (MT Newswires) -- Xencor ( XNCR ) said Tuesday it has appointed Bart Cornelissen as chief financial officer. Cornelissen most recently served as vice president of corporate finance at Seagen. Xencor ( XNCR ) shares were up 2.7% in recent trading. Price: 22.08, Change: +0.58, Percent Change: +2.67 ...
Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?
Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?
Apr 9, 2024
On Monday, Vincerx Pharma Inc ( VINC ) presented preliminary Phase 1 data for VIP236 and updates on pipeline progress at the American Association for Cancer Research Annual Meeting 2024. VNC-236-101 is a Phase 1 dose-escalation study with monotherapy VIP236 for metastatic tumor patients who have exhausted all standard therapy options.  Fifteen patients have been dosed to date on the once-every-three-weeks (Q3W) schedule:...
Nuvei Unit Secures Major Payment Institution License in Singapore
Nuvei Unit Secures Major Payment Institution License in Singapore
Apr 9, 2024
10:27 AM EDT, 04/09/2024 (MT Newswires) -- Nuvei ( NVEI ) said Tuesday the Monetary Authority of Singapore has granted its Nuvei Singapore entity a major payment institution license, extending its global reach. The license allows Nuvei ( NVEI ) to operate three types of payments services in the city state, including domestic money transfer, cross-border money transfer, and merchant...
Copyright 2023-2026 - www.financetom.com All Rights Reserved